Litcius/Paper detail

Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin

Elad Sarfaty, Nazanin Khajoueinejad, Allen T. Yu, Spiros Hiotis, Benjamin J. Golas, Umut Sarpel, Daniel M. Labow, Noah Cohen

2023Annals of Surgical Oncology14 citationsDOI

Topics & Concepts

MedicineHyperthermic intraperitoneal chemotherapyConventional PCISurgical oncologyHazard ratioInterquartile rangeSurgeryColorectal cancerInternal medicineCytoreductive surgeryPeritoneal mesotheliomaOxaliplatinProportional hazards modelSurvival rateSurvival analysisOncologyCancerMesotheliomaConfidence intervalOvarian cancerPathologyMyocardial infarctionIntraperitoneal and Appendiceal MalignanciesAdrenal and Paraganglionic TumorsOvarian cancer diagnosis and treatment
Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin | Litcius